Search

Your search keyword '"Syvanen, A"' showing total 737 results

Search Constraints

Start Over You searched for: Author "Syvanen, A" Remove constraint Author: "Syvanen, A"
737 results on '"Syvanen, A"'

Search Results

201. (R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus

202. Corrigendum: Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution

203. Association between Common Variation at the FTO Locus and Changes in Body Mass Index from Infancy to Late Childhood: The Complex Nature of Genetic Association through Growth and Development

204. In search of horizontal gene transfer

205. Genetic Risk Factors in Lupus Nephritis and IgA Nephropathy - No Support of an Overlap

206. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution.

207. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution

208. Genetic Study of IgA Nephropathy and Lupus Nephritis: No Overlap in Genetic Risk Factors in CLINICAL IMMUNOLOGY, vol 135, issue , pp S114-S114

209. Variations in folate pathway genes are associated with unexplained female infertility

210. Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogrens syndrome

211. Genome-wide association study identifies eight loci associated with blood pressure

212. Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport

213. Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling

214. Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia--a comparative study of four differently designed, high resolution microarray platforms

215. The human acrosome reaction is highly sensitive to inhibition by cyclodiene insecticides

216. Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding

219. Monovalent cations differ in their effects on transcription initiation from a sigma-70 promoter of Escherichia coli

220. A quality assessment survey of SNP genotyping laboratories

226. Transforming growth factor beta1 genotype and change in left ventricular mass during antipypertensive treatment - results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

227. Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment - results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

228. Churning out safer microbes for drug delivery

230. The Gut Mucosal Viral Reservoir in HIV-Infected Patients Is Not the Major Source of Rebound Plasma Viremia following Interruption of Highly Active Antiretroviral Therapy

231. Rapid Manufacturing with Direct Metal Laser Sintering

232. A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response

233. Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy

238. Glutathione Transferase in the Decontamination of O-P Toxins and Chlorinated Hydrocarbons

239. Horizontal gene transfer

240. A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus

245. The Relationship Between the Plasma Concentration of Irbesartan and the Antihypertensive Response Is Disclosed by an Angiotensin II Type 1 Receptor Polymorphism: Results From the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial

246. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5

247. Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations

Catalog

Books, media, physical & digital resources